Pediatrix Medical Group, Inc. (NYSE:MD) Shares Acquired by Public Sector Pension Investment Board

Public Sector Pension Investment Board increased its position in shares of Pediatrix Medical Group, Inc. (NYSE:MD) by 6.0% during the second quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 182,141 shares of the company’s stock after acquiring an additional 10,253 shares during the quarter. Public Sector Pension Investment Board owned approximately 0.22% of Pediatrix Medical Group worth $1,375,000 as of its most recent filing with the SEC.

Several other hedge funds and other institutional investors have also recently bought and sold shares of MD. Rubric Capital Management LP increased its stake in shares of Pediatrix Medical Group by 797.0% during the 2nd quarter. Rubric Capital Management LP now owns 8,150,000 shares of the company’s stock valued at $61,532,000 after acquiring an additional 7,241,400 shares during the last quarter. Invenomic Capital Management LP grew its holdings in Pediatrix Medical Group by 93.3% in the fourth quarter. Invenomic Capital Management LP now owns 1,377,951 shares of the company’s stock valued at $12,815,000 after purchasing an additional 664,955 shares during the period. Boston Partners increased its position in Pediatrix Medical Group by 34.0% during the first quarter. Boston Partners now owns 1,786,434 shares of the company’s stock worth $17,702,000 after purchasing an additional 453,254 shares during the last quarter. ClariVest Asset Management LLC purchased a new position in Pediatrix Medical Group during the second quarter worth approximately $1,721,000. Finally, Vanguard Group Inc. boosted its holdings in shares of Pediatrix Medical Group by 1.6% in the 1st quarter. Vanguard Group Inc. now owns 10,557,572 shares of the company’s stock valued at $105,892,000 after purchasing an additional 164,333 shares during the last quarter. 97.71% of the stock is owned by hedge funds and other institutional investors.

Pediatrix Medical Group Stock Performance

Pediatrix Medical Group stock opened at $12.00 on Wednesday. The firm has a market capitalization of $1.01 billion, a PE ratio of -14.12, a price-to-earnings-growth ratio of 1.64 and a beta of 1.56. Pediatrix Medical Group, Inc. has a one year low of $6.62 and a one year high of $13.01. The stock’s 50 day moving average price is $10.12 and its 200 day moving average price is $8.90. The company has a debt-to-equity ratio of 0.87, a quick ratio of 1.38 and a current ratio of 1.38.

Pediatrix Medical Group (NYSE:MD) last announced its earnings results on Tuesday, August 6th. The company reported $0.34 earnings per share for the quarter, beating the consensus estimate of $0.31 by $0.03. The business had revenue of $504.30 million during the quarter, compared to the consensus estimate of $505.49 million. Pediatrix Medical Group had a negative net margin of 12.58% and a positive return on equity of 10.59%. The business’s quarterly revenue was up .7% compared to the same quarter last year. During the same period in the prior year, the firm earned $0.37 earnings per share. As a group, sell-side analysts expect that Pediatrix Medical Group, Inc. will post 1.19 EPS for the current fiscal year.

Analysts Set New Price Targets

MD has been the subject of a number of research analyst reports. StockNews.com upgraded Pediatrix Medical Group from a “sell” rating to a “hold” rating in a report on Wednesday, August 7th. UBS Group raised their price objective on Pediatrix Medical Group from $9.00 to $10.50 and gave the stock a “neutral” rating in a report on Friday, August 9th. Deutsche Bank Aktiengesellschaft upgraded Pediatrix Medical Group from a “sell” rating to a “hold” rating and set a $8.00 target price for the company in a report on Friday, June 7th. Truist Financial increased their target price on shares of Pediatrix Medical Group from $8.00 to $10.00 and gave the stock a “hold” rating in a research report on Thursday, August 15th. Finally, Jefferies Financial Group raised shares of Pediatrix Medical Group from a “hold” rating to a “buy” rating and lifted their price target for the company from $8.00 to $14.00 in a research report on Thursday, September 26th. Five investment analysts have rated the stock with a hold rating and one has issued a buy rating to the stock. Based on data from MarketBeat, Pediatrix Medical Group has an average rating of “Hold” and a consensus price target of $10.30.

Insider Buying and Selling at Pediatrix Medical Group

In related news, Director Laura A. Linynsky sold 7,000 shares of the stock in a transaction dated Tuesday, August 27th. The stock was sold at an average price of $11.16, for a total value of $78,120.00. Following the completion of the transaction, the director now owns 30,805 shares of the company’s stock, valued at $343,783.80. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. In other Pediatrix Medical Group news, CFO C Marc Richards sold 17,438 shares of the firm’s stock in a transaction on Monday, August 12th. The shares were sold at an average price of $10.08, for a total transaction of $175,775.04. Following the completion of the transaction, the chief financial officer now directly owns 175,347 shares of the company’s stock, valued at approximately $1,767,497.76. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, Director Laura A. Linynsky sold 7,000 shares of the company’s stock in a transaction dated Tuesday, August 27th. The shares were sold at an average price of $11.16, for a total transaction of $78,120.00. Following the completion of the sale, the director now owns 30,805 shares in the company, valued at approximately $343,783.80. The disclosure for this sale can be found here. Insiders sold a total of 68,100 shares of company stock valued at $701,889 in the last ninety days. Insiders own 2.00% of the company’s stock.

About Pediatrix Medical Group

Pediatrix Medical Group, Inc, together with its subsidiaries, provides newborn, maternal-fetal, pediatric cardiology, and other pediatric subspecialty care services in the United States. It offers neonatal care services, such as clinical care to babies born prematurely or with complications within specific units at hospitals through neonatal physician subspecialists, neonatal nurse practitioners, and other pediatric clinicians.